Explore Business Standard
Don’t miss the latest developments in business and finance.
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials. Marion Biotech's cough syrup Dok-1 was linked with the death of 18 children in Uzbekistan. The incident which happened last December had prompted central and state drug authorities in India to launch a probe into the matter. "The firm's licence was under suspension since January after which a detailed inquiry was initiated. Now the licence of the firm has been cancelled by the Uttar Pradesh Drugs Controlling and Licensing Authority. The firm can no longer manufacture the syrup," a government official said. On March 3, the Noida Police had arrested three employees of Marion Biotech from its office in Sector 67 while a lookout notice was issued for two of its directors after an FIR was lodged against all of them, the official said. The FIR had come in the wake of investigation's finding that samples of Marion Biotech's drugs were
The process has been initiated for cancellation of the drug license of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials here said on Sunday. All production of drugs and other activities at the firm's campus in Sector 67 here have also been stopped completely, Gautam Buddh Nagar drug inspector Vaibhav Babbar said. On Friday, the local police arrested three senior employees of the firm after an FIR was lodged against them on charges of manufacturing and sale of adulterated drugs. The two directors of the company named in the FIR, however, still remain at large. The process has been initiated for cancellation of the drug license of pharmaceutical firm Marion Biotech. Paperwork for it is in progress and a report has been sent to the Uttar Pradesh government," Babbar told PTI. "All production at the firm had been suspended in January itself and now it has been completely
Three employees of a city-based pharmaceutical firm Marion Biotech, whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, were arrested on charges of manufacturing and sale of adulterated drugs, officials said. Meanwhile, Drugs Inspector from Central Drugs Standard Control Organization (CDSCO), North Zone, on Friday issued a notice to Marion Biotech asking it to stop the sale and distribution of the drug concerned, stating that the sample was found to be "not of standard quality". "Notice is also hereby issued to you to reply within seven days from the receipt of this letter, why action shall not be taken against you for violation of section 18(a)(i) of the act, failing which it will be presumed that you have nothing to say in this matter and necessary action shall be initiated against you without any further notice," the notice issued on March 3 said. The arrests of three employees were made after an FIR was lodged late Thursday night against
The armies of India and Uzbekistan on Monday began a two-week military exercise in Uttarakhand's Pithoragarh with an aim to enhance operational interoperability. The fourth edition of joint military exercise 'Dustlik' commenced in Foreign Training Node in Pithoragarh (Uttarakhand). Forty-five soldiers each from Uzbekistan and the Indian Army are participating in this exercise which is aimed at promoting positive relations between the two sides, the Indian Army said. The Indian Army contingent comprises troops from an infantry battalion from the Garhwal Rifles Regiment. The first edition of the exercise was held in Uzbekistan in November 2019. "The 14 days long joint exercise would focus on joint counter-terrorist operations in mountainous and semi-urban scenarios under the UN mandate and will include field training exercises, combat discussions, lectures, demonstrations and culminate with a validation exercise," the Army said. "Both sides will jointly train, plan and execute a ser
The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the results of its controversial cough syrup are awaited, an Uttar Pradesh drug official said Thursday. A team of central agencies and the Uttar Pradesh drug department had carried out an inspection at the firm's office here on December 29 and taken six more samples for testing. During the inspection, the company representatives could not produce documents related to the production of 'Dok-1 max' cough syrup, prompting the government to order halting of its production immediately, Gautam Buddh Nagar Drug Inspector Vaibhav Babbar said. "The production licence of the firm remains suspended, as was ordered on December 29. Now the suspension order has been issued in writing to the firm on January 10 and has been acknowledged by the firm," Babbar told PTI. On the status of the test results, the officer said the samples were taken